London Daily

Focus on the big picture.
Tuesday, Jul 29, 2025

Everything you need to know about Pfizer’s COVID-19 vaccine

Everything you need to know about Pfizer’s COVID-19 vaccine

Reported breakthrough in race to find coronavirus vaccine welcomed by scientists and leaders, but experts caution many questions remain.

Raising hopes for a major victory in the fight against the coronavirus pandemic, drugmakers Pfizer and BioNTech have said their experimental vaccine may be 90 percent effective at preventing COVID-19.

The announcement on Monday reverberated across the world, with stock markets surging to new records and political leaders welcoming the late-stage trial results – even as scientists and doctors cautioned many questions remained unanswered and warned any celebration would be premature.

As the efforts to contain a disease that has killed more than 1.25 million people and ravaged livelihoods globally, here is all you need to know about the promising vaccine.

What was announced?


The drugmakers’ trial involves some 44,000 people in six countries, half of whom have been administered with the vaccine, while the other half were given a placebo – a treatment designed to have no effect.

Monday’s data is from an interim analysis that was conducted after 94 participants in the continuing trial developed COVID-19. Fewer than nine of them who caught the disease had been given the vaccine.

To confirm the efficacy rate, Pfizer said it would continue its trial until there were 164 COVID-19 cases among volunteers, a number that the Food and Drug Administration (FDA) has agreed is enough to tell how well the vaccine is working.

The data, however, have yet to be peer-reviewed or published in a medical journal. Pfizer said it would do so once it has the results from the entire trial.

Outside experts said key details of the data need to be analysed and cautioned that many questions remain, including whether the vaccine can prevent severe disease or complications, how long it will protect against infection and how well it will work in the elderly.

How does this vaccine work?


When you get vaccinated, you are usually given either a weakened or a dead part of the virus, or the bacteria that causes an illness. In this way, the vaccine does not make you ill, but your body recognises that it is a foreign element and it mounts an immune response. This means that when your body comes across the real bug that causes that illness, it will be ready to attack it straight away.

The way this new vaccine works is called mRNA, meaning that you are not actually being injected with parts of the virus or a weakened form of it, but you are actually being administered with a part of the genetic code of the coronavirus. This tricks the body into producing some of the viral proteins itself so that the immune system then detects these proteins and starts to produce a defensive response to them.

What was the reaction?


Investors piled into banks stocks, airlines and other economically sensitive companies that had been battered by months of coronavirus-led lockdowns and travel bans, pushing major US stock indexes to fresh record highs.

Pfizer shares were indicated 6 percent higher in New York, while BioNTech’s US stock leapt 18 percent.

The World Health Organization said the results were very positive, but warned there was a funding gap of $4.5bn that could slow access to tests, medicines and vaccines in low- and middle-income countries.

Experts also warned there could be major challenges in distributing the vaccine, especially in poorer countries where power supplies are inadequate, as it must be stored at industrial deep-freeze temperatures to be effective.

What’s next?


Pfizer and BioNTech said they plan to apply to the FDA for emergency approval to use the vaccine by the end of the month, when they will have two months of safety data on about half of trial participants. This has raised the possibility of a regulatory decision as soon as December.

To save time, the companies began manufacturing the vaccine before they knew whether it would be effective. They now expect to produce up to 50 million doses, or enough to protect 25 million people, this year.

Pfizer said it expects to produce up to 1.3 billion doses of the vaccine in 2021.

Who is lining up to buy it?


Pfizer and BioNTech have a $1.95bn contract with the US government to deliver 100 million vaccine doses beginning this year. They have also reached supply agreements with the European Union, the United Kingdom, Canada and Japan.

Comments

Oh ya 5 year ago
So the title says everything you need to know. Well why not tell the folks what is in the vaccine? Like in most there are a bunch of poison things you do not want to put in your body like mercury, aluminum, formaldehyde, parts of aborted babies. But the sheeple will line up for the jab and the drug companies will make billions. Your life your body do as you wish, there is no law about being stupid

Newsletter

Related Articles

0:00
0:00
Close
France Opens Criminal Investigation into X Over Algorithm Manipulation Allegations
A family has been arrested in the UK for displaying the British flag
Mel Gibson refuses to work with Robert De Niro, saying, "Keep that woke clown away from me."
Trump Steamrolls EU in Landmark Trade Win: US–EU Trade Deal Imposes 15% Tariff on European Imports
ChatGPT CEO Sam Altman says people share personal info with ChatGPT but don’t know chats can be used as court evidence in legal cases.
The British propaganda channel BBC News lies again.
Deputy attorney general's second day of meeting with Ghislaine Maxwell has concluded
Controversial March in Switzerland Features Men Dressed in Nazi Uniforms
Politics is a good business: Barack Obama’s Reported Net Worth Growth, 1990–2025
Thai Civilian Death Toll Rises to 12 in Cambodian Cross-Border Attacks
TSUNAMI: Trump Just Crossed the Rubicon—And There’s No Turning Back
Over 120 Criminal Cases Dismissed in Boston Amid Public Defender Shortage
UN's Top Court Declares Environmental Protection a Legal Obligation Under International Law
"Crazy Thing": OpenAI's Sam Altman Warns Of AI Voice Fraud Crisis In Banking
The Podcaster Who Accidentally Revealed He Earns Over $10 Million a Year
Trump Announces $550 Billion Japanese Investment and New Trade Agreements with Indonesia and the Philippines
US Treasury Secretary Calls for Institutional Review of Federal Reserve Amid AI‑Driven Growth Expectations
UK Government Considers Dropping Demand for Apple Encryption Backdoor
Severe Flooding in South Korea Claims Lives Amid Ongoing Rescue Operations
Japanese Man Discovers Family Connection Through DNA Testing After Decades of Separation
Russia Signals Openness to Ukraine Peace Talks Amid Escalating Drone Warfare
Switzerland Implements Ban on Mammography Screening
Japanese Prime Minister Vows to Stay After Coalition Loses Upper House Majority
Pogacar Extends Dominance with Stage Fifteen Triumph at Tour de France
CEO Resigns Amid Controversy Over Relationship with HR Executive
Man Dies After Being Pulled Into MRI Machine Due to Metal Chain in New York Clinic
NVIDIA Achieves $4 Trillion Valuation Amid AI Demand
US Revokes Visas of Brazilian Corrupted Judges Amid Fake Bolsonaro Investigation
U.S. Congress Approves Rescissions Act Cutting Federal Funding for NPR and PBS
North Korea Restricts Foreign Tourist Access to New Seaside Resort
Brazil's Supreme Court Imposes Radical Restrictions on Former President Bolsonaro
Centrist Criticism of von der Leyen Resurfaces as she Survives EU Confidence Vote
Judge Criticizes DOJ Over Secrecy in Dropping Charges Against Gang Leader
Apple Closes $16.5 Billion Tax Dispute With Ireland
Von der Leyen Faces Setback Over €2 Trillion EU Budget Proposal
UK and Germany Collaborate on Global Military Equipment Sales
Trump Plans Over 10% Tariffs on African and Caribbean Nations
Flying Taxi CEO Reclaims Billionaire Status After Stock Surge
Epstein Files Deepen Republican Party Divide
Zuckerberg Faces $8 Billion Privacy Lawsuit From Meta Shareholders
FIFA Pressured to Rethink World Cup Calendar Due to Climate Change
SpaceX Nears $400 Billion Valuation With New Share Sale
Microsoft, US Lab to Use AI for Faster Nuclear Plant Licensing
Trump Walks Back Talk of Firing Fed Chair Jerome Powell
Zelensky Reshuffles Cabinet to Win Support at Home and in Washington
"Can You Hit Moscow?" Trump Asked Zelensky To Make Putin "Feel The Pain"
Irish Tech Worker Detained 100 days by US Authorities for Overstaying Visa
Dimon Warns on Fed Independence as Trump Administration Eyes Powell’s Succession
Church of England Removes 1991 Sexuality Guidelines from Clergy Selection
Superman Franchise Achieves Success with Latest Release
×